Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03280303 · ClinicalTrials.gov registry record
Palbociclib in Real World Practice
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 1,285
- Enrollment target
NCT03280303 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 1,285 participants.
The verdict
NCT03280303 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 1,285 participants
- Enrollment target
Study Summary
This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.
Interventions
- OTHER non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,285 participants |
| Start Date | 2017-01-04 |
| Est. Completion | 2022-12-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03280303
The ClinicalTrials.gov registry entry for NCT03280303 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which non-interventional is the first listed.
NCT03280303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03280303 about?
NCT03280303 is a clinical study titled "Palbociclib in Real World Practice". This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.
What is the current status of trial NCT03280303?
This trial is currently completed. The enrollment target is 1,285 participants. The study started on 2017-01-04. Estimated completion is 2022-12-22.
What interventions are being tested in trial NCT03280303?
The interventions under investigation include: non-interventional (OTHER).
Who is sponsoring clinical trial NCT03280303?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.